Show simple item record

dc.contributor.authorSchluger, N
dc.contributor.authorKarunakara, U
dc.contributor.authorLienhardt, C
dc.contributor.authorNyirenda, T E
dc.contributor.authorChaisson, R
dc.date.accessioned2008-06-17T11:41:17Z
dc.date.available2008-06-17T11:41:17Z
dc.date.issued2007-11-06
dc.date.submitted2008-06-13
dc.identifier.citationPLoS Med 2007;4(11):e302en
dc.identifier.issn1549-1676
dc.identifier.pmid17988170
dc.identifier.doi10.1371/journal.pmed.0040302
dc.identifier.urihttp://hdl.handle.net/10144/30095
dc.language.isoenen
dc.rightsPublished by Public Library of Science, [url]http://medicine.plosjournals.org/[/url] Archived on this site by Open Access permissionen
dc.subject.meshAntitubercular Agentsen
dc.subject.meshClinical Trials as Topicen
dc.subject.meshDrug Therapy, Combinationen
dc.subject.meshHumansen
dc.subject.meshMycobacterium tuberculosisen
dc.subject.meshTuberculosisen
dc.subject.meshTuberculosis, Multidrug-Resistanten
dc.titleBuilding clinical trials capacity for tuberculosis drugs in high-burden countriesen
dc.typeArticleen
dc.contributor.departmentDivision of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, NY, USA; Campaign for Access to Essential Medicines, Médecins Sans Frontières, Geneva, Switzerland; Clinical Trial Division, International Union Against Tuberculosis and Lung Disease, Paris, France; European and Developing Countries Clinical Trials Partnership, Cape Town, South Africa; Center for TB Research, Johns Hopkins University, Baltimore, MD, USAen
dc.identifier.journalPLoS Medicineen
refterms.dateFOA2019-03-04T10:42:13Z


Files in this item

Thumbnail
Name:
Schluger_TBclinicaltrials_pape ...
Size:
88.40Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record